Literature DB >> 19067191

Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer. A case-control study.

Xavier León1, María del Prado Venegas, César Orús, Montserrat López, Jacinto García, Miquel Quer.   

Abstract

OBJECTIVE: To evaluate the influence of persistent tobacco and alcohol use on the risk of a second metachronous neoplasm in the aerodigestive tract in head and neck squamous cell carcinoma (HNSCC) patients.
METHODS: A matched case-control study was carried out in 514 patients with HNSCC. Case patients developed a second metachronous neoplasm in the aerodigestive tract after treatment of an index HNSCC. A patient free of second neoplasm was individually matched to every case patient by location of the index tumor, tumor stage, sex, previous tobacco and alcohol consumption, age, general health status, and treatment. Data about persistence in tobacco and alcohol consumption after treatment of the index tumor was collected retrospectively. A validation study was carried out to confirm the adequacy of this retrospective information.
RESULTS: Persistent tobacco smoking and alcohol drinking after treatment of a HNSCC contributed to the risk of appearance of second neoplasm. The odds ratio of a second neoplasm for patients who continued to smoke was 2.9 (95% CI OR 1.8-4.1), and for patients who continued to use alcohol it was 5.2 (95% CI OR 3.3-7.9). There was a strong association between persistence of tobacco and alcohol use after treatment of the HNSCC index tumor. According to the attributable risk estimation, persistent tobacco and alcohol consumption would be responsible for one-third of the second neoplasms in the patients with a HNSCC index tumor.
CONCLUSIONS: Persistence of tobacco and alcohol use after treatment of a HNSCC had a significant influence on the appearance of a second neoplasm in the aerodigestive tract. Cessation of tobacco and alcohol use should be a major goal after treatment of a HNSCC.

Entities:  

Mesh:

Year:  2008        PMID: 19067191     DOI: 10.1007/s10552-008-9277-8

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  20 in total

1.  Evaluation of a biomarker based blood test for monitoring surgical resection of oral squamous cell carcinomas.

Authors:  Martin Grimm; Wiebke Kraut; Sebastian Hoefert; Michael Krimmel; Thorsten Biegner; Peter Teriete; Marcel Cetindis; Joachim Polligkeit; Susanne Kluba; Adelheid Munz; Siegmar Reinert
Journal:  Clin Oral Investig       Date:  2015-07-08       Impact factor: 3.573

Review 2.  European Laryngological Society: ELS recommendations for the follow-up of patients treated for laryngeal cancer.

Authors:  Ricard Simo; Patrick Bradley; Dominique Chevalier; Frederik Dikkers; Hans Eckel; Nayla Matar; Giorgio Peretti; Cesare Piazza; Mark Remacle; Miquel Quer
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-09       Impact factor: 2.503

Review 3.  Second primary tumors in patients with head and neck cancer.

Authors:  Antonio Vitor Martins Priante; Emanuel Celice Castilho; Luiz Paulo Kowalski
Journal:  Curr Oncol Rep       Date:  2011-04       Impact factor: 5.075

Review 4.  Survivorship in Non-Small Cell Lung Cancer: Challenges Faced and Steps Forward.

Authors:  Namrata Vijayvergia; Prashant C Shah; Crystal S Denlinger
Journal:  J Natl Compr Canc Netw       Date:  2015-09       Impact factor: 11.908

5.  Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers.

Authors:  Meredith S Shiels; Todd Gibson; Joshua Sampson; Demetrius Albanes; Gabriella Andreotti; Laura Beane Freeman; Amy Berrington de Gonzalez; Neil Caporaso; Rochelle E Curtis; Joanne Elena; Neal D Freedman; Kim Robien; Amanda Black; Lindsay M Morton
Journal:  J Clin Oncol       Date:  2014-11-10       Impact factor: 44.544

6.  Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? : A monocentric retrospective analysis of a previously defined low-risk patient population treated with standard-of-care radiotherapy.

Authors:  Yonca Onbasi; Sebastian Lettmaier; Markus Hecht; Sabine Semrau; Heinrich Iro; Marco Kesting; Rainer Fietkau; Marlen Haderlein
Journal:  Strahlenther Onkol       Date:  2019-01-04       Impact factor: 3.621

Review 7.  Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.

Authors:  Lois B Travis; Wendy Demark Wahnefried; James M Allan; Marie E Wood; Andrea K Ng
Journal:  Nat Rev Clin Oncol       Date:  2013-03-26       Impact factor: 66.675

Review 8.  Systematic Review of Tobacco Use after Lung or Head/Neck Cancer Diagnosis: Results and Recommendations for Future Research.

Authors:  Jessica L Burris; Jamie L Studts; Antonio P DeRosa; Jamie S Ostroff
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-08-17       Impact factor: 4.254

9.  Molecular etiology of second primary tumors in contralateral tonsils of human papillomavirus-associated index tonsillar carcinomas.

Authors:  Andrew W Joseph; Takenori Ogawa; Justin A Bishop; Sofia Lyford-Pike; Xiaofei Chang; Timothy H Phelps; William H Westra; Sara I Pai
Journal:  Oral Oncol       Date:  2012-10-10       Impact factor: 5.337

10.  Tobacco use in the oncology setting: advancing clinical practice and research.

Authors:  Ellen R Gritz; Benjamin A Toll; Graham W Warren
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-01       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.